Recent Finacing
Recent Raise
PMV Pharmaceuticals develops tumor-agnostic small molecules that restore mutant p53 to wild-type function to selectively induce death in p53‑mutant cancer cells.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at PMV Pharmaceuticals.
